Diabetic foot infection – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:29:56 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Diabetic foot infection – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Safety and Effectiveness of TP-102 for Treating Diabetic Foot Infections in Patients https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-tp-102-for-treating-diabetic-foot-infections-in-patients/ Wed, 29 Apr 2026 14:25:20 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-tp-102-for-treating-diabetic-foot-infections-in-patients/ This clinical trial is focused on studying a condition known as diabetic foot infection, which can occur in people with diabetes. This infection often involves bacteria such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus. The study is testing a new treatment called TP-102, which is a special mixture of bacteriophages. Bacteriophages are tiny viruses that can target and destroy specific bacteria. The treatment is applied directly to the wound on the foot. Another treatment being used in the study is a solution called sodium chloride, which is commonly used in medical settings.

The purpose of the study is to evaluate the safety and effectiveness of the TP-102 treatment in helping to heal diabetic foot infections. Participants in the study will receive either the TP-102 treatment or a placebo, in addition to the standard care they would normally receive for their condition. The study will last for about a month, during which the effects of the treatment on the infection and wound healing will be closely monitored.

Throughout the study, researchers will observe how well the treatment works in reducing the size of the wound and improving the overall condition of the infection. They will also keep track of any side effects that may occur. The goal is to determine if TP-102 can be a safe and effective option for treating diabetic foot infections, potentially offering a new way to help patients with this challenging condition.

]]> Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-contezolid-acefosamil-contezolid-and-linezolid-for-adults-with-moderate-or-severe-diabetic-foot-infections/ Wed, 29 Apr 2026 14:25:03 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-contezolid-acefosamil-contezolid-and-linezolid-for-adults-with-moderate-or-severe-diabetic-foot-infections/ This clinical trial is focused on studying the treatment of Diabetic Foot Infections, which are infections that occur in the feet of people with diabetes. The study will compare the effectiveness and safety of two medications, Contezolid Acefosamil and Contezolid, with another medication called Linezolid. These medications will be given to participants either through an intravenous infusion, which means the medicine is delivered directly into the bloodstream, or orally, which means the medicine is taken by mouth in tablet form.

The purpose of the study is to evaluate how well these medications work in treating moderate or severe diabetic foot infections. Participants will be randomly assigned to receive either the new medications, Contezolid Acefosamil and Contezolid, or the existing medication, Linezolid. Some participants may receive a placebo, which looks like the real medication but does not contain any active ingredients. The study will last for a period of up to 28 days, during which the participants’ health and response to the treatment will be closely monitored by the study team.

Throughout the study, the safety and tolerability of the medications will be assessed, meaning the researchers will check for any side effects or adverse reactions. The main goal is to see if the new medications are as effective or more effective than Linezolid in treating the infections. Participants will have regular check-ups and assessments to track their progress and the effectiveness of the treatment. The study aims to provide valuable information that could lead to improved treatment options for people with diabetic foot infections.

]]>